PPARGC1B and metabolic dysfunction-associated steatohepatitis: In addition to lipid metabolic disorders resulting from loss of Nrf1’s function to regulate LPIN1, PGC-1β and other metabolic genes [51,52], NASH has a not-yet-identified characteristic of refractory inflammation.